Flagship Pioneering as of Dec. 31, 2020
Portfolio Holdings for Flagship Pioneering
Flagship Pioneering holds 11 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Moderna (MRNA) | 58.7 | $3.2B | 31M | 104.47 | |
| Sigilon Therapeutics | 9.1 | $498M | 10M | 48.03 | |
| Seres Therapeutics (MCRB) | 6.5 | $360M | 15M | 24.50 | |
| Rubius Therapeutics | 5.3 | $291M | 38M | 7.59 | |
| Evelo Biosciences | 5.0 | $277M | 23M | 12.09 | |
| Foghorn Therapeutics (FHTX) | 4.7 | $257M | 13M | 20.27 | |
| Denali Therapeutics (DNLI) | 4.2 | $229M | 2.7M | 83.76 | |
| Kaleido Biosciences Ord (KLDO) | 3.2 | $176M | 19M | 9.10 | |
| Codiak Biosciences | 1.5 | $84M | 2.6M | 32.30 | |
| Axcella Health Inc equity | 1.2 | $65M | 13M | 5.19 | |
| Syros Pharmaceuticals | 0.6 | $32M | 2.9M | 10.85 |
